<DOC>
	<DOC>NCT01410903</DOC>
	<brief_summary>The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.</brief_summary>
	<brief_title>Immunoadsorption in Patients With Severe Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma, Systemic</mesh_term>
	<mesh_term>Scleroderma, Diffuse</mesh_term>
	<criteria>systemic sclerosis according to the ACEcriteria severe pulmonary manifestation with reduced DLCO signed informed consent inadequate peripheral venous access participation in another clinical trial heart failure pronounced allergic diathesis, particularly in case of known hypersensitivity to drugs and/or materials used in the extracorporeal circuit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>